nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ADRB1—dilated cardiomyopathy	0.514	0.543	CbGaD
Penbutolol—ADRB2—dilated cardiomyopathy	0.432	0.457	CbGaD
Penbutolol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00278	0.124	CcSEcCtD
Penbutolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00129	0.0611	CbGpPWpGaD
Penbutolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00123	0.0547	CcSEcCtD
Penbutolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.0012	0.0536	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00119	0.0531	CcSEcCtD
Penbutolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00111	0.0494	CcSEcCtD
Penbutolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00107	0.0506	CbGpPWpGaD
Penbutolol—Levobunolol—ADRB1—dilated cardiomyopathy	0.000955	0.0952	CrCbGaD
Penbutolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000955	0.0425	CcSEcCtD
Penbutolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000944	0.042	CcSEcCtD
Penbutolol—Timolol—ADRB1—dilated cardiomyopathy	0.000911	0.0908	CrCbGaD
Penbutolol—Carteolol—ADRB1—dilated cardiomyopathy	0.000812	0.081	CrCbGaD
Penbutolol—Levobunolol—ADRB2—dilated cardiomyopathy	0.000803	0.0801	CrCbGaD
Penbutolol—Timolol—ADRB2—dilated cardiomyopathy	0.000766	0.0764	CrCbGaD
Penbutolol—Nadolol—ADRB1—dilated cardiomyopathy	0.000724	0.0722	CrCbGaD
Penbutolol—Bupranolol—ADRB1—dilated cardiomyopathy	0.000691	0.0688	CrCbGaD
Penbutolol—Carteolol—ADRB2—dilated cardiomyopathy	0.000683	0.0681	CrCbGaD
Penbutolol—Sweating—Furosemide—dilated cardiomyopathy	0.00062	0.0276	CcSEcCtD
Penbutolol—Nadolol—ADRB2—dilated cardiomyopathy	0.000609	0.0607	CrCbGaD
Penbutolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000604	0.0269	CcSEcCtD
Penbutolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0006	0.0267	CcSEcCtD
Penbutolol—HTR1B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000586	0.0277	CbGpPWpGaD
Penbutolol—Bupranolol—ADRB2—dilated cardiomyopathy	0.000581	0.0579	CrCbGaD
Penbutolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000579	0.0577	CrCbGaD
Penbutolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000529	0.0528	CrCbGaD
Penbutolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000519	0.0231	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000506	0.0225	CcSEcCtD
Penbutolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000502	0.0223	CcSEcCtD
Penbutolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000502	0.0223	CcSEcCtD
Penbutolol—HTR1B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000492	0.0233	CbGpPWpGaD
Penbutolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.000487	0.0485	CrCbGaD
Penbutolol—Depression—Lisinopril—dilated cardiomyopathy	0.000484	0.0216	CcSEcCtD
Penbutolol—Headache—Spironolactone—dilated cardiomyopathy	0.000475	0.0212	CcSEcCtD
Penbutolol—HTR1B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000475	0.0225	CbGpPWpGaD
Penbutolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000465	0.0207	CcSEcCtD
Penbutolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000456	0.0216	CbGpPWpGaD
Penbutolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000453	0.0202	CcSEcCtD
Penbutolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000451	0.0201	CcSEcCtD
Penbutolol—HTR1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000446	0.0211	CbGpPWpGaD
Penbutolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000445	0.0444	CrCbGaD
Penbutolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000444	0.0198	CcSEcCtD
Penbutolol—HTR1B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000399	0.0189	CbGpPWpGaD
Penbutolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000399	0.0178	CcSEcCtD
Penbutolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000385	0.0171	CcSEcCtD
Penbutolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000384	0.0182	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000382	0.0181	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000378	0.0179	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000375	0.0178	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000372	0.0176	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000362	0.0171	CbGpPWpGaD
Penbutolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000356	0.0158	CcSEcCtD
Penbutolol—Pain—Furosemide—dilated cardiomyopathy	0.000353	0.0157	CcSEcCtD
Penbutolol—Cough—Lisinopril—dilated cardiomyopathy	0.000331	0.0147	CcSEcCtD
Penbutolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000326	0.0145	CcSEcCtD
Penbutolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000318	0.015	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000304	0.0144	CbGpPWpGaD
Penbutolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000299	0.0133	CcSEcCtD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000299	0.0142	CbGpPWpGaD
Penbutolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000296	0.0132	CcSEcCtD
Penbutolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000295	0.014	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000294	0.0139	CbGpPWpGaD
Penbutolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000289	0.0137	CbGpPWpGaD
Penbutolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000287	0.0136	CbGpPWpGaD
Penbutolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000282	0.0126	CcSEcCtD
Penbutolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000281	0.0133	CbGpPWpGaD
Penbutolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.00028	0.0125	CcSEcCtD
Penbutolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000276	0.0123	CcSEcCtD
Penbutolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000273	0.0122	CcSEcCtD
Penbutolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000273	0.0121	CcSEcCtD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000272	0.0129	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000269	0.0127	CbGpPWpGaD
Penbutolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000267	0.0119	CcSEcCtD
Penbutolol—Pain—Lisinopril—dilated cardiomyopathy	0.000265	0.0118	CcSEcCtD
Penbutolol—Headache—Furosemide—dilated cardiomyopathy	0.000259	0.0115	CcSEcCtD
Penbutolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000248	0.0248	CrCbGaD
Penbutolol—Nausea—Furosemide—dilated cardiomyopathy	0.000245	0.0109	CcSEcCtD
Penbutolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000245	0.0109	CcSEcCtD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000238	0.0113	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000233	0.011	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000228	0.0108	CbGpPWpGaD
Penbutolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000222	0.00989	CcSEcCtD
Penbutolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000212	0.00943	CcSEcCtD
Penbutolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000209	0.00991	CbGpPWpGaD
Penbutolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000209	0.0208	CrCbGaD
Penbutolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000205	0.00912	CcSEcCtD
Penbutolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000195	0.00921	CbGpPWpGaD
Penbutolol—Headache—Lisinopril—dilated cardiomyopathy	0.000194	0.00864	CcSEcCtD
Penbutolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000184	0.00819	CcSEcCtD
Penbutolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000158	0.00749	CbGpPWpGaD
Penbutolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000137	0.00647	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000135	0.00641	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000135	0.00641	CbGpPWpGaD
Penbutolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000131	0.00621	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000126	0.00596	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000126	0.00595	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000125	0.0059	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000117	0.00553	CbGpPWpGaD
Penbutolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000115	0.00546	CbGpPWpGaD
Penbutolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000113	0.00536	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000113	0.00535	CbGpPWpGaD
Penbutolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000113	0.00534	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000108	0.00509	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000108	0.00509	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000106	0.00503	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000103	0.00488	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000103	0.00488	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0001	0.00474	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0001	0.00473	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.78e-05	0.00463	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	9.69e-05	0.00459	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	9.66e-05	0.00457	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	9.58e-05	0.00454	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	9.57e-05	0.00453	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.3e-05	0.0044	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	9.22e-05	0.00436	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	9.16e-05	0.00434	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.09e-05	0.00431	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	8.89e-05	0.00421	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	8.81e-05	0.00417	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	8.61e-05	0.00408	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.57e-05	0.00406	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.57e-05	0.00406	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.38e-05	0.00397	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.38e-05	0.00397	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	8.27e-05	0.00392	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.2e-05	0.00388	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.2e-05	0.00388	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	8.19e-05	0.00388	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	8.19e-05	0.00388	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.97e-05	0.00377	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	7.85e-05	0.00372	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.79e-05	0.00369	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.69e-05	0.00364	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	7.62e-05	0.00361	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	7.62e-05	0.00361	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.55e-05	0.00357	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.52e-05	0.00356	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.38e-05	0.00349	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	7.38e-05	0.00349	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	7.36e-05	0.00348	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	7.32e-05	0.00347	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.3e-05	0.00345	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.98e-05	0.0033	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.59e-05	0.00312	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.52e-05	0.00309	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.52e-05	0.00309	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.44e-05	0.00305	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.38e-05	0.00302	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.38e-05	0.00302	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.3e-05	0.00298	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.3e-05	0.00298	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.25e-05	0.00296	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.24e-05	0.00295	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.24e-05	0.00295	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.07e-05	0.00287	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.98e-05	0.00283	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.98e-05	0.00283	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.93e-05	0.00281	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	5.82e-05	0.00276	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.8e-05	0.00275	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.75e-05	0.00272	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.62e-05	0.00266	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	5.58e-05	0.00264	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.02e-05	0.00238	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.91e-05	0.00232	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.8e-05	0.00227	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.76e-05	0.00225	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.64e-05	0.0022	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.63e-05	0.00219	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.63e-05	0.00219	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.55e-05	0.00216	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.54e-05	0.00215	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.43e-05	0.0021	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	4.43e-05	0.0021	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.3e-05	0.00204	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.2e-05	0.00199	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.2e-05	0.00199	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.17e-05	0.00197	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.91e-05	0.00185	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.79e-05	0.00179	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.69e-05	0.00175	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.69e-05	0.00175	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.61e-05	0.00171	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.61e-05	0.00171	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.56e-05	0.00169	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.53e-05	0.00167	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.53e-05	0.00167	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.53e-05	0.00167	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.51e-05	0.00166	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.45e-05	0.00164	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.43e-05	0.00162	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.38e-05	0.0016	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	3.38e-05	0.0016	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.35e-05	0.00159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.35e-05	0.00159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.35e-05	0.00159	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.28e-05	0.00155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.28e-05	0.00155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.28e-05	0.00155	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.25e-05	0.00154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.23e-05	0.00153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.2e-05	0.00152	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.2e-05	0.00152	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.18e-05	0.0015	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.11e-05	0.00147	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.07e-05	0.00145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.04e-05	0.00144	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.98e-05	0.00141	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.95e-05	0.0014	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.88e-05	0.00137	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.84e-05	0.00134	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.8e-05	0.00132	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.77e-05	0.00131	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.71e-05	0.00128	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.69e-05	0.00127	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.62e-05	0.00124	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.57e-05	0.00122	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.57e-05	0.00122	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.52e-05	0.00119	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.51e-05	0.00119	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.48e-05	0.00118	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.48e-05	0.00118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.46e-05	0.00117	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.44e-05	0.00116	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.38e-05	0.00113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.34e-05	0.00111	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.31e-05	0.00109	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.27e-05	0.00108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.24e-05	0.00106	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.23e-05	0.00105	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.18e-05	0.00103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.13e-05	0.00101	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.09e-05	0.000989	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.04e-05	0.000967	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2e-05	0.000946	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2e-05	0.000945	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.98e-05	0.000936	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.98e-05	0.000936	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.95e-05	0.000924	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.93e-05	0.000916	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.93e-05	0.000916	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.91e-05	0.000904	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.91e-05	0.000904	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.9e-05	0.000898	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.89e-05	0.000896	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.89e-05	0.000896	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.85e-05	0.000878	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.84e-05	0.000871	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.81e-05	0.000859	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.81e-05	0.000858	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.81e-05	0.000858	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.8e-05	0.000852	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.77e-05	0.000839	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.76e-05	0.000833	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.74e-05	0.000825	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.73e-05	0.000821	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.7e-05	0.000807	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.58e-05	0.000748	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.56e-05	0.000737	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.52e-05	0.00072	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.49e-05	0.000704	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.45e-05	0.000689	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.44e-05	0.000683	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.41e-05	0.000666	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.38e-05	0.000653	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.34e-05	0.000636	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.26e-05	0.000595	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.24e-05	0.000587	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.23e-05	0.000582	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.21e-05	0.000574	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.2e-05	0.000569	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.19e-05	0.000562	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.12e-05	0.00053	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.1e-05	0.000519	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.08e-05	0.000513	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.07e-05	0.000507	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.07e-05	0.000507	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.05e-05	0.000496	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.02e-05	0.000485	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.33e-06	0.000442	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.62e-06	0.000408	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.43e-06	0.000399	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.25e-06	0.00039	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.43e-06	0.000352	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.27e-06	0.000344	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.1e-06	0.000336	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.4e-06	0.000303	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.09e-06	0.000241	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.98e-06	0.000236	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.87e-06	0.000231	CbGpPWpGaD
